Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq XIANYANG, China, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement...